ERIC

ERIC

European Research Initiative on CLL: Project 7 (WP7) of the European LeukemiaNet (ELN) and EHA Scientific Working Group (SWG)

  • JOIN
    • BECOME A MEMBER
    • MAKE A DONATION
    • SUBMIT A PROPOSAL
  • ABOUT
    • INTRODUCTION
    • STRUCTURE
    • PARTNERS
    • CONTACT
  • ACTIONS
    • PROJECTS
    • MEETINGS
    • NETWORKS
  • RESOURCES
    • PUBLICATIONS
    • VIDEOS
    • RECOMMENDATIONS
  • NEWS
    • NEWS ARCHIVE
    • NEWSLETTERS
  • FOR PATIENTS
    • PEOPLE WITH CLL
    • HEALTHCARE PROFESSIONALS
  • PLATFORMS
    • PEDRO: AE management
  • office@ericll.org
  • Data protection
ERIC
BECOME A MEMBER MAKE A DONATION SUBMIT A PROPOSAL

SLIDES ELN 2026 🔗

  • Agenda
  • Welcome and Introduction (Paolo Ghia)
  • Effectiveness and safety of I+V treatment in patients with CLL (Thomas Chatzikonstantinou)
  • TP53 aberrations in patients treated with targeted agents (Sunil Iyengar)
  • Outcomes of patients belonging to subset#2 and have received 1L treatment (Thomas Chatzikonstantinou)
  • RESOLVE trial_Andy Rawstron